Form4insider filings, from the source

SEC Form 3 · accession 0000899243-19-003492

TCR2 THERAPEUTICS INC. · TCRR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Garry E Menzel
Officer — President & CEO · Director
Period of report
Feb 13, 2019
Accepted (ET)
Feb 13, 2019 · 6:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001750019

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1holding———84,527ISee Footnote

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2$0.74holding————Dec 12, 2026Common Stock253,581—D
Stock Option (Right to Buy)F3$0.74holding————Dec 6, 2027Common Stock143,977—D
Stock Option (Right to Buy)F4$5.88holding————Jul 25, 2028Common Stock433,037—D

Explanation of responses

Remarks

Exhibit 24.1: Power of Attorney